Efficacy of Evolocumab vs low‐density lipoprotein cholesterol apheresis in patients with familial hypercholesterolemia and high cardiovascular risk (EVOLAFER01)

Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk

Patient Preference and Adherence ◽

10.2147/ppa.s182765 ◽

2018 ◽

Vol Volume 13 ◽

pp. 9-19 ◽

Cited By ~ 6

Author(s):

Julius Katzmann ◽

Felix Mahfoud ◽

Michael Böhm ◽

Martin Schulz ◽

Ulrich Laufs

Keyword(s):

Blood Pressure ◽

Cardiovascular Risk ◽

Medication Adherence ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

POLYGENIC CONTRIBUTION TO LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND CARDIOVASCULAR RISK IN MONOGENIC FAMILIAL HYPERCHOLESTEROLEMIA

Canadian Journal of Cardiology ◽

10.1016/j.cjca.2020.07.181 ◽

2020 ◽

Vol 36 (10) ◽

pp. S93

Author(s):

L. Brunham ◽

M. Trinder ◽

M. Paquette ◽

A. Baass

Keyword(s):

Cardiovascular Risk ◽

Familial Hypercholesterolemia ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Levels

Switching From Atorvastatin to Simvastatin in Patients at High Cardiovascular Risk: Effects on Low-Density Lipoprotein Cholesterol

American Journal of Therapeutics ◽

10.1097/mjt.0b013e3181b442b9 ◽

2010 ◽

Vol 17 (2) ◽

pp. 167-175 ◽

Cited By ~ 20

Author(s):

Herbert D Aronow ◽

Gregory Hess ◽

Jerrold Hill ◽

Andreas Kuznik ◽

Larry Z Liu

Keyword(s):

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Risk Effects

GETTING TO AN IMPROVED UNDERSTANDING OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND DYSLIPIDEMIA MANAGEMENT (GOULD): A REGISTRY OF HIGH CARDIOVASCULAR RISK PATIENTS IN THE UNITED STATES

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(18)32308-8 ◽

2018 ◽

Vol 71 (11) ◽

pp. A1767

Author(s):

Christopher P. Cannon ◽

James de Lemos ◽

Robert Rosenson ◽

Christie Ballantyne ◽

Brian Boatman ◽

...

Keyword(s):

United States ◽

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

The United States ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Risk Patients

The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.55350 ◽

2021 ◽

Vol 28 (1) ◽

pp. 79-89 ◽

Cited By ~ 1

Author(s):

Mayu Higashioka ◽

Satoko Sakata ◽

Takanori Honda ◽

Jun Hata ◽

Mao Shibata ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Distance To Targets Of Low-Density Lipoprotein Cholesterol And Eligibility For Treatment With Pcsk9 Inhibitors In Patients At High Cardiovascular Risk

Atherosclerosis ◽

10.1016/j.atherosclerosis.2019.06.561 ◽

2019 ◽

Vol 287 ◽

pp. e185-e186

Author(s):

F. Barkas ◽

M. Elisaf ◽

T. Dimitriou ◽

G. Liamis ◽

E. Rizos ◽

...

Keyword(s):

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Pcsk9 Inhibitors

Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States

American Heart Journal ◽

10.1016/j.ahj.2019.10.014 ◽

2020 ◽

Vol 219 ◽

pp. 70-77 ◽

Cited By ~ 1

Author(s):

Christopher P. Cannon ◽

James A. de Lemos ◽

Robert S. Rosenson ◽

Christie M. Ballantyne ◽

Yuyin Liu ◽

...

Keyword(s):

United States ◽

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

The United States ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Risk Patients

Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans

European Journal of Clinical Investigation ◽

10.1046/j.1365-2362.1996.2030543.x ◽

1996 ◽

Vol 26 (11) ◽

pp. 960-965 ◽

Cited By ~ 8

Author(s):

B. FAGERBERG ◽

O. WIKLUND ◽

S. AGEWALL ◽

G. CAMEJO ◽

R. J. WIKSTRAND

Keyword(s):

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

CONSISTENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL LOWERING EFFICACY OF ALIROCUMAB IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL >100/70 MG/DL AT BASELINE

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(17)35101-x ◽

2017 ◽

Vol 69 (11) ◽

pp. 1712

Author(s):

Jennifer Robinson ◽

Francois Schiele ◽

Ulrich Laufs ◽

Maddalena Lettino ◽

Velichka Valcheva ◽

...

Keyword(s):

Cardiovascular Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Cholesterol Lowering ◽

Risk Patients ◽

Very High

LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) VALUES AMONG HIGH CARDIOVASCULAR RISK PATIENTS IN A REAL WORLD POPULATION

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(16)32035-6 ◽

2016 ◽

Vol 67 (13) ◽

pp. 2034

Author(s):

Rajeshwari S. Punekar ◽

Kathleen Fox ◽

Akshara Richhariya ◽

Shravanthi Gandra ◽

Mark Cziraky ◽

...

Keyword(s):

Cardiovascular Risk ◽

Real World ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

World Population ◽

Low Density ◽

Risk Patients